Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QAT5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0061504 | cyclic threonylcarbamoyladenosine biosynthetic process | 7 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 2 | 11 |
GO:0016829 | lyase activity | 2 | 2 |
GO:0016835 | carbon-oxygen lyase activity | 3 | 2 |
GO:0016836 | hydro-lyase activity | 4 | 2 |
GO:0016874 | ligase activity | 2 | 11 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 3 | 11 |
GO:0061503 | tRNA threonylcarbamoyladenosine dehydratase | 5 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 2 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 2 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 2 |
GO:0140657 | ATP-dependent activity | 1 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 122 | 126 | PF00656 | 0.266 |
CLV_C14_Caspase3-7 | 167 | 171 | PF00656 | 0.299 |
CLV_NRD_NRD_1 | 180 | 182 | PF00675 | 0.325 |
CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.504 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.280 |
CLV_PCSK_FUR_1 | 253 | 257 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 253 | 255 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.255 |
CLV_PCSK_PC1ET2_1 | 255 | 257 | PF00082 | 0.473 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.482 |
CLV_PCSK_PC1ET2_1 | 267 | 269 | PF00082 | 0.459 |
CLV_PCSK_PC7_1 | 258 | 264 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.236 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.454 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.511 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.445 |
DEG_SPOP_SBC_1 | 58 | 62 | PF00917 | 0.299 |
DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.288 |
DOC_MAPK_MEF2A_6 | 92 | 99 | PF00069 | 0.222 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.251 |
DOC_USP7_MATH_1 | 70 | 74 | PF00917 | 0.222 |
DOC_USP7_UBL2_3 | 255 | 259 | PF12436 | 0.426 |
DOC_USP7_UBL2_3 | 262 | 266 | PF12436 | 0.454 |
DOC_WW_Pin1_4 | 269 | 274 | PF00397 | 0.631 |
LIG_Actin_WH2_2 | 223 | 240 | PF00022 | 0.373 |
LIG_Clathr_ClatBox_1 | 68 | 72 | PF01394 | 0.236 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.280 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.355 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.327 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.368 |
LIG_FHA_2 | 165 | 171 | PF00498 | 0.306 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.222 |
LIG_LIR_Nem_3 | 55 | 59 | PF02991 | 0.370 |
LIG_MYND_1 | 201 | 205 | PF01753 | 0.465 |
LIG_SH2_CRK | 56 | 60 | PF00017 | 0.368 |
LIG_SH2_NCK_1 | 56 | 60 | PF00017 | 0.368 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.222 |
LIG_SH3_2 | 202 | 207 | PF14604 | 0.447 |
LIG_SH3_3 | 199 | 205 | PF00018 | 0.416 |
LIG_SH3_4 | 204 | 211 | PF00018 | 0.437 |
LIG_Sin3_3 | 233 | 240 | PF02671 | 0.333 |
LIG_SUMO_SIM_anti_2 | 189 | 197 | PF11976 | 0.368 |
LIG_SUMO_SIM_anti_2 | 50 | 55 | PF11976 | 0.388 |
LIG_SUMO_SIM_par_1 | 157 | 163 | PF11976 | 0.386 |
LIG_SUMO_SIM_par_1 | 67 | 74 | PF11976 | 0.260 |
LIG_SUMO_SIM_par_1 | 95 | 100 | PF11976 | 0.326 |
LIG_TYR_ITIM | 54 | 59 | PF00017 | 0.280 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.384 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.284 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.302 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.464 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.411 |
MOD_GSK3_1 | 188 | 195 | PF00069 | 0.365 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.582 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.658 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.236 |
MOD_N-GLC_1 | 217 | 222 | PF02516 | 0.376 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.480 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.502 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.368 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.291 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.367 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.242 |
MOD_OFUCOSY | 123 | 129 | PF10250 | 0.280 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.321 |
MOD_Plk_1 | 188 | 194 | PF00069 | 0.456 |
MOD_Plk_1 | 213 | 219 | PF00069 | 0.499 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.307 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.222 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.341 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.397 |
MOD_ProDKin_1 | 269 | 275 | PF00069 | 0.636 |
MOD_SUMO_rev_2 | 257 | 264 | PF00179 | 0.480 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.257 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.368 |
TRG_ER_diArg_1 | 114 | 117 | PF00400 | 0.222 |
TRG_ER_diArg_1 | 253 | 256 | PF00400 | 0.461 |
TRG_ER_diArg_1 | 85 | 88 | PF00400 | 0.280 |
TRG_NLS_Bipartite_1 | 253 | 270 | PF00514 | 0.526 |
TRG_NLS_MonoCore_2 | 265 | 270 | PF00514 | 0.509 |
TRG_NLS_MonoExtC_3 | 265 | 270 | PF00514 | 0.515 |
TRG_NLS_MonoExtN_4 | 263 | 270 | PF00514 | 0.512 |
TRG_Pf-PMV_PEXEL_1 | 85 | 89 | PF00026 | 0.280 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6Q3 | Leptomonas seymouri | 85% | 100% |
A0A0S4KJM6 | Bodo saltans | 68% | 84% |
A0A1X0NJ23 | Trypanosomatidae | 66% | 95% |
A0A3Q8ICX5 | Leishmania donovani | 96% | 100% |
A0A422P452 | Trypanosoma rangeli | 68% | 100% |
A4I0N6 | Leishmania infantum | 91% | 100% |
D0A715 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 100% |
E9AWN6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 92% |
O32037 | Bacillus subtilis (strain 168) | 37% | 100% |
Q46927 | Escherichia coli (strain K12) | 37% | 100% |
Q57097 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 34% | 100% |
V5BVX4 | Trypanosoma cruzi | 68% | 84% |